Today's Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAVVF Advantage Energy	Reiterated by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.05 -0.5%		Neutral
ADSK Autodesk	Target Raised by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew DeGasperi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$257.33 -4.9%	$295.00 ➝ $300.00	Outperform
ADSK Autodesk	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nick Altmann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$257.33 -4.9%	$300.00	Buy
ADSK Autodesk	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clarke Jeffries Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$257.33 -4.9%	$369.00 ➝ $338.00	Overweight
ADSK Autodesk	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Jester Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$257.33 -4.9%	$262.00 ➝ $283.00	Market Perform
ADSK Autodesk	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Taylor McGinnis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$257.33 -4.9%	$290.00 ➝ $325.00	Buy
ADSK Autodesk	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tamjid Chowdhury Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$257.33 -4.9%	$277.00 ➝ $283.00	Buy
ADSK Autodesk	Target Set by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clark Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$257.33 -4.9%	$325.00
AFRM Affirm	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Moshe Orenbuch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.32 +3.7%	$117.00 ➝ $124.00	Buy
AFRM Affirm	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Faucette Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.32 +3.7%	$80.00 ➝ $82.00	Equal Weight
The retirement stock I'd buy before Nvidia today (Ad) In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Chaikin Money Flow indicator has a new top retirement pick. The company holds three fast-growing businesses -- including an autonomous vehicle unit and a streaming service with 10x Netflix's reach -- any of which could be spun off in the next 12 to 24 months. It also pays a dividend, a rarity among high-growth AI names. Chaikin lays out the full case in a new free presentation, no email or credit card required. Get Marc Chaikin's free presentation on this overlooked AI stock now
AFRM Affirm	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timothy Chiodo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.32 +3.7%	$82.00 ➝ $90.00	Neutral
AFRM Affirm	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Peterson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.32 +3.7%	$90.00 ➝ $100.00	Buy
AFRM Affirm	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Carcache Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.32 +3.7%	$103.00 ➝ $115.00	Overweight
AFRM Affirm	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rayna Kumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.32 +3.7%	$100.00 ➝ $104.00	Outperform
AFRM Affirm	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Friedman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.32 +3.7%	$105.00 ➝ $110.00	Positive
AFRM Affirm	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Keane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.32 +3.7%		Market Outperform
AFRM Affirm	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nik Cremo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.32 +3.7%	$97.00 ➝ $105.00	Overweight
AFRM Affirm	Reiterated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$80.32 +3.7%		Outperform
AFRM Affirm	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Kupferberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.32 +3.7%	$93.00 ➝ $104.00	Buy
AFRM Affirm	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ramsey El-Assal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.32 +3.7%	$88.00	Overweight
AFRM Affirm	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rufus Hone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.32 +3.7%	$86.00 ➝ $101.00	Outperform
AFRM Affirm	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Connor Allen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.32 +3.7%	$90.00 ➝ $105.00	Overweight
AFRM Affirm	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Perlin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.32 +3.7%	$80.00 ➝ $96.00	Sector Perform
AIZ Assurant	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Charlie Lederer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$286.90 +0.5%	$274.00 ➝ $320.00	Outperform
ALL Allstate	Reiterated by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Heal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$260.34 +1.1%		Buy ➝ Hold
ALL Allstate	Target Set by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Heal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$260.34 +1.1%	$238.00
AMZN Amazon.com	Target Set by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$265.12 +3.5%	$315.00 ➝ $355.00	Outperform
AVAH Aveanna Healthcare	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Mok Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.31 -3.7%	$9.50 ➝ $15.00	Overweight
AVNW Aviat Networks	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$20.43 -4.7%		Market Outperform
AVNW Aviat Networks	Reiterated by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dave Kang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.43 -4.7%	$28.00 ➝ $33.00	Buy
AVNW Aviat Networks	Reiterated by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Searle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.43 -4.7%	$34.00 ➝ $38.00	Buy
BABA Alibaba Group	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shyam Patil Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$118.42 +1.8%	$185.00 ➝ $190.00	Positive
BBW Build-A-Bear Workshop	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keegan Cox Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.44 +3.5%	$60.00 ➝ $37.00	Buy
BBY Best Buy	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Baker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.35 -1.4%	$90.00 ➝ $95.00	Buy
BBY Best Buy	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Forbes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.35 -1.4%	$90.00 ➝ $95.00	Buy
BBY Best Buy	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Seth Sigman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.35 -1.4%	$77.00 ➝ $85.00	Buy
BBY Best Buy	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simeon Gutman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.35 -1.4%	$80.00 ➝ $90.00	Equal Weight
BBY Best Buy	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lasser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.35 -1.4%	$86.00 ➝ $90.00	Neutral
BBY Best Buy	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kate McShane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.35 -1.4%	$62.00 ➝ $71.00	Sell
BHVN Biohaven	Target Set by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sumant Kulkarni Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.47 -4.0%	$21.00
It’s not about Greenland (Ad) The petrodollar arrangement that anchored the US dollar for 50 years quietly expired in June 2024. Since then, China has cut its Treasury holdings by 45% from their peak, and BRICS nations offloaded $47 billion of American debt in a single month. The Trump administration has responded with a $12 billion critical minerals stockpile called Project Vault, equity stakes in miners like MP Materials and Lithium Americas, and a push to secure resources from Greenland to Ukraine. Porter Stansberry lays out the full story in a new documentary, including five companies positioned at the chokepoints of what he calls Trump's New Dollar. Watch the full documentary before December's economic summit in Miami
BIDU Baidu	Target Lowered by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shyam Patil Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$96.95 +0.0%	$140.00 ➝ $105.00	Neutral
BILI Bilibili	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$16.57 -1.1%		Buy
BILI Bilibili	Target Set by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$16.57 -1.1%	$29.00
BLCO Bausch + Lomb	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.04 -0.5%	$21.00	Buy
BULL Webull	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Brendler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.38 -2.0%	$15.00	Buy
BURL Burlington Stores	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Straton Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$275.23 -5.1%	$438.00 ➝ $432.00	Overweight
BURL Burlington Stores	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Lejuez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$275.23 -5.1%	$380.00 ➝ $318.00	Neutral
BURL Burlington Stores	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$275.23 -5.1%	$323.00	Hold
BURL Burlington Stores	Target Lowered by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aneesha Sherman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$275.23 -5.1%	$365.00 ➝ $355.00	Outperform
BURL Burlington Stores	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ike Boruchow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$275.23 -5.1%	$370.00
BZUN Baozun	Upgraded by	CLSA Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Wenting Yu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.09 +2.3%	$3.20 ➝ $3.80	Hold ➝ Outperform
CHH Choice Hotels International	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robin Farley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$108.80 +0.2%	$119.00 ➝ $120.00	Neutral
CIZN Citizens	Target Set by	Nomura Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.49 +0.9%	$12.00
CM Canadian Imperial Bank of Commerce	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Darko Mihelic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$113.87 -0.8%		Outperform
CPB Campbell's	Target Set by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jim Salera Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.37 +0.4%	$20.00
CSIQ Canadian Solar	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Maheep Mandloi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.00 -7.0%	$18.00 ➝ $17.00	Neutral
CTVA Corteva	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Arun Viswanathan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$83.11 +0.9%		Overweight
CV CapsoVision	Initiated by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$6.01 -0.8%	$9.00	Buy
DG Dollar General	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Keith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.50 -1.9%	$118.00 ➝ $123.00	Neutral
DG Dollar General	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simeon Gutman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.50 -1.9%	$132.00 ➝ $145.00	Equal Weight
DG Dollar General	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Lejuez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.50 -1.9%	$116.00 ➝ $133.00	Neutral
DG Dollar General	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kate McShane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.50 -1.9%	$128.00 ➝ $141.00	Neutral
DG Dollar General	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bobby Griffin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.50 -1.9%	$150.00	Outperform
DG Dollar General	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$123.50 -1.9%	$160.00	Outperform
DG Dollar General	Target Raised by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Bottiglieri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.50 -1.9%	$113.00 ➝ $129.00	Neutral
DG Dollar General	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kelly Bania Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.50 -1.9%	$120.00 ➝ $135.00	Market Perform
DG Dollar General	Target Raised by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Feldman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.50 -1.9%	$125.00 ➝ $140.00	Market Perform
DLB Dolby Laboratories	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Frankel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$60.51 -3.0%	$85.00	Buy
DLTR Dollar Tree	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Zhihan Ma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$129.13 +1.7%	$130.00	Market Perform
DLTR Dollar Tree	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kelly Bania Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$129.13 +1.7%	$135.00	Market Perform
DLTR Dollar Tree	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bobby Griffin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$129.13 +1.7%	$145.00	Outperform
DLTR Dollar Tree	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simeon Gutman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$129.13 +1.7%	$130.00 ➝ $145.00	Equal Weight
DLTR Dollar Tree	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lasser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$129.13 +1.7%	$145.00 ➝ $150.00	Buy
DOCU Docusign	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Bullock Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$64.46 +1.0%		Underperform
DTE DTE Energy	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Thalacker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.54 -0.5%	$150.00 ➝ $143.00	Market Perform
EH EHang	Downgraded by	Dbs Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.48 -3.9%		Buy ➝ Hold
EMR Emerson Electric	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Snyder Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$155.02 -1.7%	$125.00 ➝ $135.00	Underweight
EPM Evolution Petroleum	Upgraded by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Grampp Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.64 +1.7%	$4.00	Market Perform ➝ Outperform
ESI Element Solutions	Target Set by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$33.98 -7.0%	$48.00
ESTC Elastic	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.84 +20.4%	$104.00 ➝ $128.00	Buy
ESTC Elastic	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Owens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.84 +20.4%	$85.00 ➝ $130.00	Overweight
ESTC Elastic	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$100.84 +20.4%		Hold
ESTC Elastic	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Radi Sultan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.84 +20.4%	$85.00 ➝ $105.00	Buy
ESTC Elastic	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Howard Ma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.84 +20.4%	$106.00 ➝ $120.00	Buy
ESTC Elastic	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Radi Sultan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.84 +20.4%		Buy
ESTC Elastic	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Reback Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.84 +20.4%	$90.00 ➝ $107.00	Buy
ESTC Elastic	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Owens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.84 +20.4%		Hold
ESTC Elastic	Reiterated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Colville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.84 +20.4%		Sector Perform
ESTC Elastic	Target Set by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Blakey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.84 +20.4%	$100.00
ESTC Elastic	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Koji Ikeda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.84 +20.4%	$90.00 ➝ $108.00	Neutral
The retirement stock I'd buy before Nvidia today (Ad) In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Chaikin Money Flow indicator has a new top retirement pick. The company holds three fast-growing businesses -- including an autonomous vehicle unit and a streaming service with 10x Netflix's reach -- any of which could be spun off in the next 12 to 24 months. It also pays a dividend, a rarity among high-growth AI names. Chaikin lays out the full case in a new free presentation, no email or credit card required. Get Marc Chaikin's free presentation on this overlooked AI stock now
ESTC Elastic	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shrenik Kothari Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.84 +20.4%	$95.00 ➝ $120.00	Outperform
ESTC Elastic	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ittai Kidron Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.84 +20.4%	$100.00 ➝ $118.00	Outperform
ESTC Elastic	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Essex Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.84 +20.4%	$93.00 ➝ $105.00	Overweight
ESTC Elastic	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.84 +20.4%	$100.00 ➝ $120.00	Buy
ESTC Elastic	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sanjit Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.84 +20.4%	$66.00 ➝ $75.00	Equal Weight
ESTC Elastic	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kingsley Crane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.84 +20.4%	$80.00 ➝ $120.00	Buy
ETN Eaton	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Snyder Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$404.35 -2.8%	$500.00 ➝ $520.00	Overweight
FDX FedEx	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Tyler Brown Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$330.08 -0.4%	$330.00
FINV PPDAI Group	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Judy Zhang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.37 -16.2%	$8.10 ➝ $4.10	Buy ➝ Neutral
FIVE Five Below	Target Set by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Feldman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$242.33 -1.9%	$260.00 ➝ $280.00	Outperform
GAP GAP	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lorraine Hutchinson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.42 +12.7%	$26.00 ➝ $27.00	Neutral
GAP GAP	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Drbul Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.42 +12.7%	$26.00 ➝ $27.00	Buy
GAP GAP	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonna Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.42 +12.7%	$23.00 ➝ $27.00	Buy
GAP GAP	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Straton Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.42 +12.7%	$21.00 ➝ $23.00	Equal Weight
GAP GAP	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adrienne Yih Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.42 +12.7%	$20.00 ➝ $23.00	Equal Weight
GAP GAP	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jay Sole Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.42 +12.7%	$40.00 ➝ $42.00	Buy
GAP GAP	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ike Boruchow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.42 +12.7%	$22.00 ➝ $23.00	Cautious
GDWN Goodwin	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		£188.08 +3.3%		House Stock
GENB Generate Biomedicines	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.10 -4.2%	$25.00 ➝ $30.00	Buy
GENI Genius Sports	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.30 +4.3%		Buy
GNSS Genasys	Target Lowered by	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Woo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.43 -7.7%	$6.00 ➝ $5.00	Buy
GRG Greggs	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,854 +0.4%	GBX 1,610 ➝ GBX 1,740	Hold
HEI Heico	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Godyn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$331.32 -1.7%	$429.00 ➝ $441.00	Buy
HOC Hochschild Mining	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 667.50 -0.7%	GBX 570 ➝ GBX 800	Buy
HPQ HP	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.48 +2.9%	$19.00 ➝ $23.00	Underweight
HQY HealthEquity	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Larsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$95.72 +2.5%	$115.00	Buy
HQY HealthEquity	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$95.72 +2.5%		Market Outperform
HQY HealthEquity	Target Set by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$95.72 +2.5%	$111.00
HRL Hormel Foods	Target Lowered by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Max Gumport Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.37 +0.4%	$27.00 ➝ $26.00	Neutral
HRL Hormel Foods	Target Set by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Pooran Sharma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.37 +0.4%	$23.00
IREN IREN	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$35.04 -13.5%		Market Outperform
IREN IREN	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Lewis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.04 -13.5%	$80.00	Buy
IREN IREN	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Knoblauch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.04 -13.5%	$99.00	Overweight
IREN IREN	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Vafi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.04 -13.5%	$79.00	Buy
IREN IREN	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Colonnese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.04 -13.5%	$90.00	Buy
IREN IREN	Reiterated by	Compass Point Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$35.04 -13.5%	$85.00	Buy
IVT InvenTrust Properties	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Gorman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.71 +0.2%	$37.00	Buy
JAZZ Jazz Pharmaceuticals	Target Set by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leonid Timashev Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$246.55 -1.8%	$299.00
LFVN Lifevantage	Target Raised by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brooks O'Neil Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.61 +2.5%	$5.00 ➝ $6.00	Hold
LGRDY LeGrand	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$32.13 +1.2%		Overweight
LMRI Lumexa Imaging	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Mok Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.46 -2.3%	$9.00 ➝ $13.00	Overweight
LUCK Lucky Strike Entertainment	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Wieczynski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.56 +4.8%	$9.00 ➝ $8.00	Buy
LUCK Lucky Strike Entertainment	Target Set by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$6.56 +4.8%	$6.50
MACF Macfarlane Group	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 77 +3.8%	GBX 82	Hold
MBRX Moleculin Biotech	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sara Nik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.65 -5.2%	$3.00	Buy
MBUU Malibu Boats	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$27.46 -4.7%		Buy
MDT Medtronic	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Jennings Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$91.15 +1.3%	$100.00 ➝ $110.00	Buy
MLM Martin Marietta Materials	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Codling Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$529.88 +0.2%	$610.00 ➝ $620.00	Sector Perform
MRNA Moderna	Upgraded by	Bradesco Corretora Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$137.48 -3.7%		Outperform
MRNA Moderna	Initiated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Myles Minter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$137.48 -3.7%		Outperform
The retirement stock I'd buy before Nvidia today (Ad) In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Chaikin Money Flow indicator has a new top retirement pick. The company holds three fast-growing businesses -- including an autonomous vehicle unit and a streaming service with 10x Netflix's reach -- any of which could be spun off in the next 12 to 24 months. It also pays a dividend, a rarity among high-growth AI names. Chaikin lays out the full case in a new free presentation, no email or credit card required. Get Marc Chaikin's free presentation on this overlooked AI stock now
MRNA Moderna	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$137.48 -3.7%		Hold
MRNA Moderna	Upgraded by	CLSA Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$137.48 -3.7%		Outperform
MRNA Moderna	Upgraded by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Eade Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$137.48 -3.7%	$180.00	Hold ➝ Buy
MRVL Marvell Technology	Target Lowered by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Ellis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$216.88 -10.2%	$345.00 ➝ $315.00	Buy
MRVL Marvell Technology	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Buchalter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$216.88 -10.2%	$225.00 ➝ $245.00	Hold
MRVL Marvell Technology	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	N. Quinn Bolton Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$216.88 -10.2%	$270.00 ➝ $300.00	Buy
MRVL Marvell Technology	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C.J. Muse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$216.88 -10.2%	$300.00	Neutral
MRVL Marvell Technology	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rick Schafer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$216.88 -10.2%	$300.00 ➝ $325.00	Outperform
MRVL Marvell Technology	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Moore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$216.88 -10.2%	$224.00 ➝ $246.00	Equal Weight
MRVL Marvell Technology	Target Raised by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christian Schwab Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$216.88 -10.2%	$217.00 ➝ $300.00	Buy
MRVL Marvell Technology	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Vinh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$216.88 -10.2%		Overweight
MRVL Marvell Technology	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Schneider Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$216.88 -10.2%	$220.00
MRVL Marvell Technology	Reiterated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$216.88 -10.2%	$280.00	Outperform
NAT Nordic American Tankers	Target Raised by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Liam Burke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.73 -0.4%	$7.50 ➝ $8.00	Buy
NEXA Nexa Resources	Reiterated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Orest Wowkodaw Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.31 -4.2%	$15.00	Sector Perform
NIQ NIQ Global Intelligence	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Meuler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.29 +1.2%	$17.00 ➝ $23.00	Outperform
NTNX Nutanix	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$69.52 -0.5%	$53.00 ➝ $75.00	Equal Weight
OKTA Okta	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gabriela Borges Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$169.68 -1.9%	$126.00 ➝ $203.00	Buy
OKTA Okta	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shyam Patil Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$169.68 -1.9%	$110.00 ➝ $185.00	Neutral
OSG Octave Specialty Group	Initiated by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.60 +2.0%	$8.00	Outperform
OTGLY CD Projekt	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$15.70 -0.3%		Underweight
P Everpure	Target Raised by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nehal Chokshi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.33 -4.9%	$90.00 ➝ $128.00	Outperform
P Everpure	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.33 -4.9%	$84.00 ➝ $110.00	Equal Weight
PANW Palo Alto Networks	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Gallo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$370.21 -3.3%	$335.00 ➝ $450.00	Buy
PD PagerDuty	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kingsley Crane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.87 +9.8%	$10.00 ➝ $15.00	Buy
PD PagerDuty	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sanjit Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.87 +9.8%	$9.00 ➝ $10.00	Underweight
PEP PepsiCo	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Moskow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$140.79 +0.8%		Hold
PRU Prudential	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,018 +0.4%	GBX 1,500	Buy
PURR Hyperliquid Strategies	Target Raised by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James McIlree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.01 -6.4%	$9.75 ➝ $17.00	Buy
PYPL PayPal	Target Lowered by	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dominick Gabriele Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.86 -12.4%	$62.00 ➝ $50.00	Hold
PYPL PayPal	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Dolev Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.86 -12.4%	$51.00
RARE Ultragenyx Pharmaceutical	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.85 -1.6%	$46.00 ➝ $50.00	Overweight
RBRK Rubrik	Reiterated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Todd Weller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.27 -11.9%		Overweight
RBRK Rubrik	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Fish Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.27 -11.9%	$91.00 ➝ $114.00	Overweight
RBRK Rubrik	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Fatima Boolani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.27 -11.9%		Buy
RBRK Rubrik	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rudy Kessinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.27 -11.9%	$90.00 ➝ $115.00	Buy
RBRK Rubrik	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gray Powell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.27 -11.9%	$109.00 ➝ $125.00	Buy
RBRK Rubrik	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Ruykhaver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.27 -11.9%	$120.00	Overweight
RBRK Rubrik	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Heath Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.27 -11.9%	$112.00 ➝ $120.00	Overweight
RBRK Rubrik	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.27 -11.9%	$98.00 ➝ $115.00	Outperform
RBRK Rubrik	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Saket Kalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.27 -11.9%	$110.00 ➝ $115.00	Overweight
RBRK Rubrik	Reiterated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick O'Neill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.27 -11.9%	$120.00	Outperform
RBRK Rubrik	Target Set by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$94.27 -11.9%	$120.00
RCEL Avita Medical	Target Raised by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Frank Takkinen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.37 +0.5%	$8.00 ➝ $12.00	Buy
RDNT RadNet	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Mok Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$75.55 +0.3%	$65.00 ➝ $79.00	Overweight
RNG RingCentral	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Reilly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$69.85 +1.9%	$55.00 ➝ $85.00	Buy
ROIV Roivant Sciences	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.50 -5.5%	$41.00	Buy
RVMD Revolution Medicines	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Schmitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$208.50 -5.7%	$240.00 ➝ $275.00	Buy
RVMD Revolution Medicines	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Yee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$208.50 -5.7%	$220.00 ➝ $265.00	Buy
RY Royal Bank Of Canada	Reiterated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$204.36 -0.1%		Outperform
Why major institutions are piling into this digital asset now (Ad) BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned. Get the name, the ticker, and exactly how to buy it
RYTM Rhythm Pharmaceuticals	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Hoang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$108.53 -3.6%	$120.00	Hold
S SentinelOne	Reiterated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Colville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.15 -6.9%		Outperform
S SentinelOne	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Owens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.15 -6.9%	$15.00 ➝ $20.00	Neutral
S SentinelOne	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Roger Boyd Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.15 -6.9%	$16.00 ➝ $24.00	Neutral
S SentinelOne	Reiterated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Todd Weller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.15 -6.9%	$26.00	Overweight
S SentinelOne	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Weed Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.15 -6.9%	$19.00 ➝ $21.00	Outperform
S SentinelOne	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hamza Fodderwala Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.15 -6.9%	$17.00 ➝ $23.00	Equal Weight
S SentinelOne	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Fatima Boolani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.15 -6.9%		Outperform
S SentinelOne	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kingsley Crane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.15 -6.9%	$18.00 ➝ $25.00	Buy
S SentinelOne	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Ruykhaver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.15 -6.9%	$26.00	Overweight
S SentinelOne	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.15 -6.9%	$20.00 ➝ $26.00	Buy
S SentinelOne	Target Raised by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rustam Kanga Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.15 -6.9%	$23.00 ➝ $25.00	Market Outperform
S SentinelOne	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Catharine Trebnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.15 -6.9%	$25.00	Buy
S SentinelOne	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shaul Eyal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.15 -6.9%	$25.00 ➝ $26.00	Buy
S SentinelOne	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Fatima Boolani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.15 -6.9%	$17.00 ➝ $23.00	Neutral
S SentinelOne	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Saket Kalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.15 -6.9%	$22.00 ➝ $23.00	Equal Weight
S SentinelOne	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Gallo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.15 -6.9%	$26.00
S32 South32	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 277 +0.4%	GBX 310	Buy
SQM Sociedad Quimica y Minera	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lucas Ferreira Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.14 -1.6%	$100.00 ➝ $94.00	Neutral
SRAD Sportradar Group	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Hickey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.18 +3.1%		Buy
STDN Standard Nuclear	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Dendrinos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.13 -1.3%	$11.00 ➝ $13.00	Outperform
STDN Standard Nuclear	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Gengaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.13 -1.3%	$17.00
STNE StoneCo	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kaio Prato Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.56	$15.00 ➝ $13.00	Buy
SWONF SoftwareOne	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.52		Buy
TBBB BBB Foods	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rodrigo Alcantara Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.11 +0.8%	$51.00 ➝ $58.00	Buy
TGOPY 3i Group	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.64 -1.0%		Buy
THFF First Financial Corporation Indiana	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Damon Delmonte Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.21 -0.4%	$78.00 ➝ $84.00	Market Perform
TMC TMC the metals	Initiated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.88 -4.1%	$10.00	Buy
TOL Toll Brothers	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jade Rahmani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$145.11 0.0%	$161.00 ➝ $170.00	Outperform
ULTA Ulta Beauty	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$515.25 -4.6%	$700.00	Strong-Buy
ULTA Ulta Beauty	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Baker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$515.25 -4.6%	$585.00 ➝ $625.00	Buy
ULTA Ulta Beauty	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lorraine Hutchinson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$515.25 -4.6%	$685.00 ➝ $650.00	Buy
ULTA Ulta Beauty	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sydney Wagner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$515.25 -4.6%	$650.00	Buy
ULTA Ulta Beauty	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adrienne Yih Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$515.25 -4.6%	$647.00 ➝ $645.00	Overweight
ULTA Ulta Beauty	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Zaccone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$515.25 -4.6%	$560.00 ➝ $580.00	Neutral
ULTA Ulta Beauty	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kate McShane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$515.25 -4.6%	$648.00 ➝ $667.00	Buy
ULTA Ulta Beauty	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lasser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$515.25 -4.6%	$735.00 ➝ $710.00	Buy
ULTA Ulta Beauty	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lasser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$515.25 -4.6%	$631.00
URBN Urban Outfitters	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$81.18 +3.0%		Neutral
VCTR Victory Capital	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$119.66 -1.2%	$117.00
VEEV Veeva Systems	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$278.65 -1.2%	$190.00 ➝ $273.00	Neutral
VTEX VTEX	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cesar Medina Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.57 +1.1%	$4.00	Overweight ➝ Equal Weight
WDAY Workday	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Weiss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$206.35 +6.6%	$145.00 ➝ $180.00	Underweight
WDAY Workday	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Enders Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$206.35 +6.6%	$139.00 ➝ $201.00	Neutral
WDAY Workday	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$206.35 +6.6%	$215.00 ➝ $225.00	Overweight
WDAY Workday	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Reback Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$206.35 +6.6%	$115.00 ➝ $160.00	Hold
WDAY Workday	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Moerdler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$206.35 +6.6%	$216.00 ➝ $238.00	Outperform
WDAY Workday	Reiterated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$206.35 +6.6%		Outperform
WDAY Workday	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$206.35 +6.6%	$230.00
WDAY Workday	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$206.35 +6.6%	$220.00 ➝ $240.00	Outperform
WDAY Workday	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$206.35 +6.6%	$220.00
WDAY Workday	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$206.35 +6.6%	$200.00 ➝ $224.00	Overweight
WDAY Workday	Target Set by	Capital One Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$206.35 +6.6%	$219.00	Overweight ➝ Equal Weight
WDAY Workday	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$206.35 +6.6%	$180.00 ➝ $230.00	Buy
WDAY Workday	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Billy Fitzsimmons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$206.35 +6.6%	$145.00 ➝ $190.00	Neutral
WDAY Workday	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew VanVliet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$206.35 +6.6%	$220.00 ➝ $205.00	Overweight
WDAY Workday	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Jester Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$206.35 +6.6%	$182.00 ➝ $230.00	Outperform
WDAY Workday	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Celino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$206.35 +6.6%	$158.00 ➝ $215.00	Overweight
WDAY Workday	Target Raised by	Monness Crespi & Hardt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$206.35 +6.6%	$202.00 ➝ $218.00	Buy
WDAY Workday	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lucky Schreiner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$206.35 +6.6%	$135.00 ➝ $190.00	Neutral
WDAY Workday	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$206.35 +6.6%	$220.00 ➝ $210.00	Hold
WULF TeraWulf	Initiated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jed Dorsheimer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.31 -7.2%		Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 02:31 PM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings